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SUMMARY
Adult muscle stem cells (satellite cells) are required for adult skeletal muscle regeneration. A proper balance between quiescence, prolif-
eration, and differentiation is essential for the maintenance of the satellite cell pool and their regenerative function. Although the ubiq-
uitin-proteasome is required for most protein degradation in mammalian cells, how its dysfunction affects tissue stem cells remains
unclear. Here, we investigated the function of the proteasome in satellite cells using mice lacking the crucial proteasomal component,
Rpt3. Ablation of Rpt3 in satellite cells decreased proteasome activity. Proteasome dysfunction in Rpt3-deficient satellite cells impaired
their ability to proliferate, survive and differentiate, resulting in defective muscle regeneration. We found that inactivation of proteaso-
mal activity induced proliferation defects and apoptosis in satellite cells. Mechanistically, insufficient proteasomal activity upregulated
the p53 pathway, which caused cell-cycle arrest. Our findings delineate a critical function of the proteasome system in maintaining
satellite cells in adult muscle.
INTRODUCTION
Adult muscle stem cells, also known as muscle satellite
cells, which are the resident tissue stem cells of skeletal
muscle, provide myonuclei for postnatal muscle growth
and for maintenance and regeneration in adults (Blau
et al., 2015; Morgan and Partridge, 2003; Relaix and Zam-
mit, 2012; Yin et al., 2013). Satellite cells are located be-
tween the basal lamina and the plasmalemma of myofibers
(Mauro, 1961). Postnatal myogenesis comprises the activa-
tion of quiescent satellite cells, the proliferation of myo-
blasts (activated satellite cells), and the fusion of myoblasts
into multinucleated fibers. Myogenesis is a complex pro-
cess that is controlled by the spatiotemporal expression
of transcription factors including myogenic regulatory fac-
tors (MRFs) (Braun and Gautel, 2011; Parker et al., 2003;
Wagers and Conboy, 2005).
The ubiquitin-proteasome pathway is responsible for
most protein degradation in mammalian cells (Collins
and Goldberg, 2017). Proteasomal degradation is mediated
by the 26S proteasome, which is an ATP-dependent prote-
ase complex that is present in both the cytoplasm and
nucleus. The ubiquitin-proteasome pathway has emerged
as a central player in the regulation of several diverse
cellular processes and functions by catalyzing the selective
degradation of short-lived regulatory proteins as well as
abnormal proteins. Thus, understanding the role of the
proteasome in each cell and tissue type is essential for com-
prehending the maintenance of homeostasis.
The 26S proteasome is composed of one proteolytically
active cylinder-shaped particle (the 20S proteasome) and
ATPase-containing complexes (the 19S cap complexes)
(Baumeister et al., 1998). The 19S cap complex unfolds
ubiquitin-conjugated proteins to allow their entry into
the 20S cylindrical particle. It also contains several putative
ATPases, such as Rpt1–6. These subunits form a large family
with a highly conserved ATPase domain (Sakao et al.,
2000). Rpt3, also known as PSMC4, is an essential subunit
of the 26S proteasome and is required for the degradation
of most proteasomal substrates. In particular, Rpt3-defi-
cient mice die before implantation due to a defect in blas-
tocyst development (Sakao et al., 2000); this indicates
that Rpt3 is essential for survival. Interestingly, an inser-
tion/deletion variant in intron 5 of the Rpt3 gene was
frequently found in a cohort of patients with Parkinson’s
disease (Marx et al., 2007). To explore the organ- and cell-
specific role of the proteasome, we generated proteasome-
deficient mice by targeting Rpt3 (Kitajima et al., 2014;
Tashiro et al., 2012). Previously, we found that conditional
knockout of Rpt3 in motor neurons results in locomotor
dysfunction, which was accompanied by progressive mo-
tor neuron loss and gliosis in mice (Tashiro et al., 2012).
Recently, we also reported that muscle-specific Rpt3
knockout mice exhibit proteasome insufficiency, leading
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to obvious muscle atrophy (Kitajima et al., 2014).
Furthermore, centrally nucleated regenerating fibers were
observed inmuscle-specific Rpt3 knockoutmice, indicating
the involvement in muscle regeneration. However, it
remains unclear how the proteasome system regulates sat-
ellite cells. Here, we investigated the pathophysiological ef-
fect of proteasome insufficiency induced by depletion of
Rpt3 on satellite cells in vivo and in vitro by using satellite
cell-specific Rpt3-knockout mice.
RESULTS
Proteasome Activity in Skeletal Muscle during Muscle
Regeneration
As the first step to determine proteasome activity in muscle
during skeletal muscle regeneration, we induced skeletal
muscle injury by injecting cardiotoxin (CTX) into the tibia-
lis anterior (TA)muscle inmice. First, we analyzed the regen-
erative capacity of C57BL/6Jmice over time (Figure S1A).On
days 14 and 30 after injury, theweight of CTX-injectedmus-
cles was significantly increased compared with that of intact
muscles (Figure S1B). At 30 days post injury, the mean TA
muscleweight per bodyweightwas also increased compared
with that of intact muscle (Figure S1C). Furthermore, histo-
logical analysis revealed extensive muscle damage and the
infiltration of inflammatory cells into the muscle at 3 days
post CTX injection, whereas centrally nucleated regenerat-
ingfibers began tobe visible at day7post injury (Figure S1D).
Following muscle injury, satellite cells start to expressMyoD
and becomemyoblasts (PAX7+/MYOD + cells) to proliferate
(Yin et al., 2013). Quantitative PCR (qPCR) analysis
confirmed that mRNA levels of MyoD, Pax7, and Myh3,
markers of regenerating fibers, peaked at day 3 post injury
(Figure S1E).
We next examined the proteasome system during regen-
eration after CTX-induced muscle injury. The ubiquitin-
proteasome system degrades most long- and short-lived
normal and abnormal intracellular proteins (Collins and
Goldberg, 2017; Goldberg, 2003). We used lysates from re-
generating muscle tissue to evaluate chymotrypsin-like
and trypsin-like proteasome activities duringmuscle regen-
eration.Chymotrypsin-like and trypsin-like proteasomeac-
tivities drastically increased to a peak level at 3 days post
injury, progressively declined until day 14, and then re-
turned to levels comparable to those observed in uninjured
control tissues by 30 post injury (Figures 1A and 1B).
Becausemost proteasomal substratesmust be ubiquitinated
before degradation (Schrader et al., 2009), we analyzed
ubiquitinated proteins during muscle regeneration by
Figure 1. Proteasome Activity in Skeletal
Muscle during Muscle Regeneration
(A) Time course for CTX treatment and tissue
harvesting.
(B) Chymotrypsin-like and trypsin-like pro-
teasome activities (relative to those in intact
tissue) in tibialis anterior (TA) muscles at 3,
7, and 14 days after injury are shown.
Data represent means ± SEM (t test: *p <
0.05, **p < 0.01, ***p < 0.001 versus intact;
n = 3–5 per group). IU, international units.
(C) Immunoblotting analysis of ubiquitin in
the TA muscles at 3, 7, and 14 days post
injury. Data represent means ± SEM (t test:
***p < 0.001 versus intact; n = 3–5 per
group).
(D) Time course analysis of satellite cells at
3 days after injury.
(E) Chymotrypsin-like and trypsin-like pro-
teasome activities (relative to those in intact
satellite cells) in satellite cells sorted from TA
muscles at 3 days post injury. Data represent
means ± SEM (t test: ***p < 0.001 versus
intact satellite cells; n = 4–5 per group). IU,
international units.
See also Figures S1.
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immunoblotting. Consistent with the proteasomal activ-
ities, we showed that the amount of ubiquitinated proteins
increased, peaking at 3 days after injury and then returning
to basal levels by 30 days post injury (Figure 1C). Because
chymotrypsin-like and trypsin-like proteasome activity
dramatically increased to a peak level 3 days after injury
(Figure 1B), we then examined proteasome activity in
onlymyocytes, excluding non-muscle cells, such as inflam-
matory cells, on day 3 post injury. At this time point,
chymotrypsin-like and trypsin-like proteasome activities
were significantly higher in myoblasts from injured ani-
mals, compared with those from control mice (Figures 1D,
1E, S1F, and S1G). These results showed that proteasome ac-
tivity is dramatically increased in skeletal muscle andmyo-
blasts during the early phase of muscle regeneration.
Satellite Cell-specific Rpt3-Knockout Mice Exhibit No
Obvious Phenotype in Muscle
To investigate the function of the proteasome system in
satellite cells, we generated satellite cell-specific Rpt3 condi-
tional knockout (Rpt3-scKO) mice by crossing Pax7CreERT2
mice (Lepper and Fan, 2010) with Rpt3f/f mice (Kitajima
et al., 2014; Tashiro et al., 2012). Previously, we reported
that deficiency of Rpt3 in skeletal muscle or motor neurons
causes proteasome insufficiency (Kitajima et al., 2014; Ta-
shiro et al., 2012). First, we examined the expression levels
of Rpt3 in muscle stem cells during proliferation and differ-
entiation. Upon activation, muscle satellite cells prolifer-
ate, downregulate Pax7, and differentiate (Kitajima and
Ono, 2018; Yin et al., 2013). Rpt3 gene expression in satel-
lite cell-derivedmyoblasts did not differ during the prolifer-
ation and differentiation processes (Figure S2). Genetic
inactivation of Rpt3 was induced by repeated intraperito-
neal injection of tamoxifen (Tmx) into adult Pax7CreERT2/+;
Rpt3f/f mice, using Tmx-treated Rpt3f/f littermates as the
wildtype control (Figure 2A). Following Tmx treatment
in vivo, Rpt3 expression was significantly reduced in satel-
lite cells (Figure 2B). In addition, chymotrypsin-like and
trypsin-like proteasome activities were significantly lower
in satellite cells from Rpt3-scKO mice (Figure 2C). More-
over, Rpt3 gene knockdown was performed in the C2C12
myoblast cell line (Figure S3A). Two small interfering
RNAs (siRNAs) were used and siRNA (#2) resulted in a
greater than 90% reduction in Rpt3 expression (Figure S3B),
and thus was used in further experiments. Evaluation of
proteasome function revealed that chymotrypsin-like and
trypsin-like protease activities were significantly decreased
48 and 72 hr after gene knockdown (Figure S3C). These re-
sults revealed the efficiency of the satellite cell-specific Rpt3
conditional knockout in our mouse model.
Next, we investigated the effect of Rpt3 deficiency in sat-
ellite cells on skeletal muscle in vivo. There was no change
in body weight between control and Rpt3-scKO mice
from 1 to 8 months after Tmx treatment (Figure 2D). There
was also no difference in TA muscle weight (Figure 2E) and
H&E staining of muscle cross sections (Figure 2F) 2 months
after Tmx treatment. Other than limb muscles, in the dia-
phragm, there was no difference in the H&E staining of
muscle cross sections and muscle cross-sectional area,
1 month after Tmx treatment (Figures S4A–S4C). Further-
more, when we performed an endurance test to investigate
muscle function, there was no significant difference be-
tween control and Rpt3-scKO mice (Figure 2G). These re-
sults suggest that satellite cell-specific Rpt3 knockout has
no obvious effect on intact muscle in mice.
Satellite Cell-specific Rpt3-scKO Mice Are Associated
with a Remarkable Defect in Regeneration
To evaluate the role of Rpt3 in satellite cells during muscle
regeneration in vivo, we genetically inactivated Rpt3
via five daily intraperitoneal injections of Tmx into
Pax7CreERT2/+; Rpt3f/f mice. Intramuscular injection of CTX
was performed to induce regeneration of the TA muscle af-
ter 2 days of Tmx treatment (Figure 3A). We showed the
muscle weight was markedly decreased in Rpt3-scKO mice
after regeneration compared with that in control mice at
day 7 and 14 post CTX treatment (Figures 3B–3D). Corre-
spondingly, histological analysis confirmed a significant
defect in muscle regeneration accompanied by a consider-
able number of infiltrating inflammatory cells in Rpt3-scKO
mice at day 14 after CTX treatment, although efficient
muscle regeneration accompanied by centrally nucleated
myofibers was observed in control mice (Figure 3E). Immu-
nohistochemistry also revealed incomplete regeneration
with marked fibrosis at day 14 post CTX treatment in
Rpt3-scKOmice (Figure 3F). In addition, the cross-sectional
area of the regenerated fibers was decreased at day 14 post
CTX treatment in Rpt3-scKO mice (Figure 3G). To evaluate
muscle regeneration in the early phase, we assessed the
expression of MYOD, which is a marker of myoblasts.
MYOD+ cells were not frequently found in Rpt3-scKO
mice 3 days after CTX treatment (Figure 3H). Taken
together, our data indicate that the function of Rpt3 in sat-
ellite cell is indispensable for muscle regeneration in vivo.
Loss of Rpt3 Leads to a Depletion of the Quiescent
Satellite Cell Pool
Previous studies have confirmed the absolute necessity of
PAX7-positive satellite cells for muscle regeneration (Lep-
per et al., 2011; Relaix and Zammit, 2012; Sambasivan
et al., 2011; von Maltzahn et al., 2013). Because muscle
regeneration was impaired in Rpt3-scKO mice, we next
examined how Rpt3 knockout affects quiescent satellite
cells in adult resting skeletal muscles. After 5 consecutive
days of Tmx injection, we found a surprisingly rapid
decline in the number of quiescent satellite cells in freshly
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isolated extensor digitorum longus (EDL) myofibers from
Rpt3-scKO mice, but not in those from control mice (Fig-
ures 4A–4C). Specifically, 20% of quiescent satellite cells
were lost within 5 days, 80% were lost within 10 days,
and 90% were lost within 15 days in Rpt3-scKO mice (Fig-
ure 4C). Similarly, immunofluorescence staining for PAX7
and laminin in TA muscle cross sections indicated the
robust ablation (90% loss) of PAX7+ quiescent satellite cells
in Rpt3-scKO mice at day 15 after Tmx treatment (Figures
4D and 4E). In addition, immunofluorescence staining
for M-cadherin, as another satellite cell marker in TA and
diaphragm muscles, revealed a robust decrease in satellite
cells in Rpt3-scKO mice (Figures 4F, 4G, S4D, and S4E).
We further analyzed the number of quiescent satellite cells
in limbmuscles by flow cytometry.We confirmed the rapid
depletion of the satellite cell fraction in Rpt3-scKO mice,
consistent with immunohistochemical analysis (Figures
4H, 4I, and S5A–S5D). These results demonstrate that loss
of Rpt3 leads to depletion of quiescent satellite cells in adult
resting muscle.
Figure 2. Satellite Cell-specific Rpt3-Knockout Mice Exhibit No Obvious Skeletal Muscle Phenotype
(A) Time course for tamoxifen (Tmx) treatment and tissue harvesting. Con indicates Rpt3f/f mice and scKO indicates satellite cell-specific
Rpt3-knockout mice (Pax7CreERT2/+; Rpt3f/f).
(B) Relative expression of Rpt3 mRNA in freshly isolated satellite cells derived from Con and scKO mice after Tmx injection. Data represent
means ± SEM (t test: ***p < 0.001; n = 4 per group). AU, arbitrary units.
(C) Chymotrypsin-like and trypsin-like proteasome activities (relative to Con) in freshly isolated satellite cells derived from Con and scKO
mice after Tmx injection. Data represent means ± SEM (t test: **p < 0.01; n = 4–5 per group). IU, international units.
(D) Change in body weight (g) after Tmx injection. Data represent mean ± SD (NS, statistically nonsignificant, n = 5–10 per group).
(E) Change in tibialis anterior (TA) muscle weight (g) at 2 months after Tmx injection. Data represent mean ± SD (NS, statistically
nonsignificant, n = 4–6 per group).
(F) H&E staining of intact TA muscle 2 months after Tmx injection. Scale bar, 50 mm. Also shown in Figure S1D.
(G) Endurance time(s) of Con and scKO mice. Data represent mean ± SD (NS, statistically nonsignificant, n = 4–6 per group).
See also Figures S2–S4.
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Deficiency of Rpt3 in Satellite Cells Results in
Proliferative Defects during Muscle Regeneration
In Vivo
To clarify whether the loss of satellite cells in Rpt3-scKO
mice is caused by apoptosis, we performed apoptosis exper-
iments using Cleaved-Caspase 3 in vivo (Figure 5A).
Numbers of Cleaved-Caspase 3+ cells relative to PAX7+
cells were significantly increased in the intact TA muscle
of Rpt3-scKO mice, 3 days after Tmx treatment (Figure 5B).
Next, to elucidate cell proliferation in the satellite cells of
Rpt3-scKO mice in vivo, we performed EdU incorporation
assays and immunostaining for KI67, a proliferativemarker
that is not expressed in G0 cells (Figure 5C). The prolifera-
tive ability of intact TA muscle in Rpt3-scKO mice was not
different from that in control mice (Figures 5D and 5E).
Moreover, to examine the proliferative potential of Rpt3-
scKO satellite cells during muscle regeneration, an EdU
incorporation assay was performed (Figure 5F). EdU+
M-cadherin+ cells were significantly decreased in Rpt3-
scKO mice when compared with the control mice (Fig-
ure 5G). These data suggested that the deficiency of Rpt3
in satellite cells results in proliferative defects during mus-
cle regeneration in vivo.
Deletion of Rpt3 in Satellite Cells Induces a
Proliferation Defect and Apoptosis
We next focused on how the proliferative state of satellite
cells is affected by proteasome dysfunction mediated
by Rpt3-deficiency in vitro. Satellite cells isolated from
Pax7CreERT2/+; Rpt3f/f mice were plated and treated with
4-hydroxy tamoxifen (4OH-Tmx) for 2 days to genetically
delete Rpt3 in satellite cells (Figure 6A). Expression of Rpt3
was suppressed by 85% in Rpt3 KO satellite-cell-derived
myoblasts compared with that in control myoblasts (Fig-
ure 6B). Cell proliferation was evaluated by performing
EdU incorporation assays in vitro. The proliferative ability
of Rpt3-deficient primary myoblasts was decreased
compared with that in controls (Figure 6C). In addition,
to investigate whether cell proliferation defects also occur
after Rpt3 knockdown in other cells, Rpt3-knockdown
experiments were performed using primary fibroblasts
(Figure S6A). Cell proliferation was suppressed in primary
fibroblasts with Rpt3-knockdown compared with that in
controls (Figures S6B and S6C).
We next asked if Rpt3-knockout-satellite cells can un-
dergo myogenic differentiation. Two days after the induc-
tion of differentiation, control myoblasts already displayed
an obviously elongated morphology, a hallmark of differ-
entiation (Figures S7A and S7B). In contrast, Rpt3-scKO
primary myoblasts were mostly spherical (Figure S7B),
indicative of a differentiation defect. We further quantified
the differentiation index, which measures the fraction of
myonuclei that are located in myosin heavy chain
(MyHC+)-expressing cells. Although greater than 50% of
nuclei in the control were located in MyHC+ cells, only
15% of nuclei in Rpt3-scKO mice were found in MyHC+
cells (Figure S7B).
To determine if the reduction in satellite cell-derived
myoblasts proliferationwas also due to cell death, apoptosis
was evaluated by performing TUNEL assays. TUNEL-posi-
tive apoptotic cells were detected more frequently in pri-
mary myoblasts of Rpt3-scKO mice (Figure 6D). This was
further supported by the upregulation of Cleaved-Caspase
3, an indicator of apoptosis, in Rpt3-inactivated primary
myoblasts (Figure 6E). Consistent with these results, the
number of cells was reduced in Rpt3-scKO mice compared
with that in control mice (Figure 6F). Upon knockdown
of Rpt3, proliferation and cell numbers decreased, whereas
apoptotic cells were more frequently detected in Rpt3-abla-
ted cells (Figures 6G–6J). These results demonstrate that
proteasome dysfunctionmediated by Rpt3 deficiency in sat-
ellite cells induces a proliferation defect and apoptosis.
p53 Knockdown in Rpt3-Deficient Satellite Cells
Rescues the Defect in Proliferation
We next investigated the molecular mechanism un-
derlying Rpt3 deficiency-induced dysfunction in activated
satellite cells. To identify the pathways affected by Rpt3
Figure 3. Satellite Cell-specific Deletion of Rpt3 Prevents Muscle Regeneration
(A) Time course for tamoxifen (Tmx) and cardiotoxin (CTX) treatment. Con indicates Rpt3f/f mice and scKO indicates satellite cell-specific
Rpt3 knockout mice (Pax7CreERT2/+; Rpt3f/f).
(B) Representative images of tibialis anterior (TA) muscles in Con and scKO mice.
(C and D) Change in (C) muscle weight (mg) and (D) muscle weight (mg)/body weight (g). Data represent mean ± SEM (t test: *p < 0.05,
**p < 0.01 versus Con, n = 5–9 per group).
(E) H&E staining of intact muscles and those injured by CTX injection, analyzed at 3, 7, and 14 days post injury. Scale bar, 50 mm.
(F) Immunostaining of collagen I (red) and DAPI (blue) in TA muscle cryosections from scKO mice 14 days after injury. Scale bar, 100 mm.
The y axis shows the mean collagen I fluorescence intensity (ratio). Data represent means ± SEM (t test: ***p < 0.001; n = 5 per group).
(G) Immunostaining of Laminin (red) and DAPI (blue) in TA muscle cryosections from scKO mice 14 days after injury. Scale bar, 100 mm.
The y axis shows the mean cross-sectional area (CSA). Data represent means ± SD (t test: **p < 0.01; n = 3 per group).
(H) Immunostaining for MYOD (green), Laminin2a, and DAPI (blue) in TA muscle cryosections from scKOmice 3 days after injury. Scale bar,
50 mm. The y axis shows the relative ratio of MYOD-positive areas. Data represent means ± SD (t test: **p < 0.01; n = 3 per group).
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Figure 4. Rpt3 Inactivation Depletes the Satellite Cell Pool
(A) Time course of tamoxifen (Tmx) treatment and tissue harvesting. Con indicates Rpt3f/f mice and scKO indicates satellite cell-specific
Rpt3 knockout mice (Pax7CreERT2/+; Rpt3f/f).
(B) Immunostaining for PAX7 (green) and DAPI (blue) in the extensor digitorum longus (EDL) single fiber 5 days after Tmx induction.
Arrows indicate satellite cells. Scale bar, 50 mm.
(legend continued on next page)
Stem Cell Reports j Vol. 11 j 1523–1538 j December 11, 2018 1529
deficiency in an unbiased manner, we performed microar-
ray analysis of quiescent satellite cells from control and
Rpt3-scKO mice (accession number GSE114354). We iden-
tified 1,254 genes that were up- or downregulated with
p values < 0.05 (Table S2). Significantly differentially ex-
pressed genes were imported into the DAVID v6.7 annota-
tion tool, and Kyoto Encyclopedia of Genes and Genomes
(KEGG) pathway analysis was performed. The enrichment
of specific pathway components into functionally regu-
lated gene groups was characterized with reference to the
KEGG pathway database. This analysis identified the top
two categories as being related to the proteasome and p53
signaling pathways (Figure 7A).
p53 is known to inhibit cell proliferation by both block-
ing cell-cycle progression and promoting apoptotic cell
death (Vousden and Prives, 2009). As shown in Figures
6C, 6D, 6H, and 6I, suppression of cell proliferation and in-
duction of apoptotic cell death was observed in Rpt3-scKO
mice. We therefore examined whether the p53 pathway is
involved in the regulation of Rpt3-scKO satellite cells. Satel-
lite cells isolated from Pax7CreERT2/+;Rpt3f/fmicewere plated
and then treated with 4OH-Tmx for 2 days to genetically
delete Rpt3 in satellite cells (Figure 7B). Expression of Rpt3
was suppressed by 80% in Rpt3 KO satellite-cell-derived
myoblasts compared with that in control myoblasts (Fig-
ure 7C). As expected, levels of p53, as well as p21, which
is a well-known p53-downstream target, were elevated,
whereas Cyclind1 and Cdk4, which are cell-cycle-related
genes associated with p53, were suppressed in Rpt3-scKO
satellite cell-derived myoblasts (Figure 7C). Consistent
with mRNA levels, western blotting also demonstrated a
dramatic increase in p53 protein and its phosphorylation
(ser392) in Rpt3-scKO satellite cell-derived myoblasts
(Figure 7D). p53-related proliferation is regulated by phos-
phorylated Rb, which was decreased in Rpt3-scKO satellite
cell-derived myoblasts (Figure 7D). Moreover, based on
immunohistochemistry, a greater than 20-fold increase in
the number of p53-positive cells was confirmed in Rpt3
KO satellite-cell-derived myoblasts as compared with those
in controls (Figure 7E). These results demonstrate that Rpt3
deletion in satellite-cell-derivedmyoblasts leads to the acti-
vation of p53 signaling in satellite cells.
Finally, to test if activation of p53 signaling is responsible
for the inhibition of proliferation in Rpt3-scKO mice, we
examined the effect of p53 silencing on Rpt3-null satellite
cell-derived myoblasts. p53 knockdown was performed in
C2C12 cells (Figure S7C). Two siRNAs were used and siRNA
(#2) showed greater than 90% reduction in p53 gene
expression (Figures S7D–S7F) and was thus used for further
experiments. Satellite cells isolated from Pax7CreERT2/+;
Rpt3f/f mice were plated and then treated with 4OH-Tmx
for 2 days after p53 siRNA transfection (Figure 7F). Impor-
tantly, the proliferative ability as well as the number of cells
were both restored in Rpt3-null myoblasts when trans-
fected with p53 siRNA (Figures 7G, 7H, S7G, and S7I),
although the differentiation ability was not improved
with p53 knockdown (Figures S7J and S7K). Taken together,
these results show that knockdown of p53 rescues defective
proliferation in Rpt3-deficient primary myoblasts.
DISCUSSION
In this study, we report that the proteasome system is indis-
pensable for themaintenance ofmuscle stem cells. Ablation
ofRpt3 in satellite cells impairs their ability toproliferate, sur-
vive, and differentiate, resulting in a severe defect in muscle
regeneration.Wealso found thatproteasome inactivationby
Rpt3 deficiency in primary myoblasts inhibits cell prolifera-
tion and induces apoptosis. Further, proteasome dysfunc-
tionconferredby satellite cell-specificRpt3knockout induces
p53 activation. Previously, it was determined that p53 in-
hibits cell proliferation by both blocking cell-cycle progres-
sion and promoting apoptotic cell death (Vousden and
Prives, 2009). We also found that p53 knockdown rescued
cell proliferation defects in Rpt3-deficient myoblasts.
(C) Number of satellite cells per fresh EDL myofiber from Con and scKO mice 0–15 days after Tmx treatment. Data represent mean ± SEM
(t test: *p < 0.05, ***p < 0.001; day 0, n = 5; day 3, n = 4; day 5, n = 5; day 10, n = 5; day 15, n = 4 per group; more than 15 myofibers per
animal).
(D) Immunostaining for PAX7 (green), laminin (red), and DAPI (blue) in tibialis anterior (TA) muscle cryosections 5 days after Tmx
treatment. Arrows indicate satellite cells. Scale bar, 20 mm.
(E) Average number of satellite cells per 100 fibers. Data represent mean ± SEM (t test: **p < 0.01; day 5, n = 4; day 15, n = 5 for each
group).
(F) Immunostaining for M-cadherin (green), Laminin2a (red), and DAPI (blue) in intact TA muscle cryosections from scKO mice. Arrows
indicate satellite cells. Scale bar, 50 mm.
(G) Average number of M-cadherin+ cells per 100 fibers. Data represent means ± SD (t test: ***p < 0.001; n = 3 per group).
(H) Fluorescence-activated cell sorting profiles of mononuclear cells derived from Con and scKO mice 2 and 15 days after Tmx treatment.
The gated profiles show satellite cell fractions (SM/C-2.6 + CD31 CD45 Sca1) from Con and scKO mice.
(I) Relative satellite cell fractions from Con and scKO mice. Data represent mean ± SEM (t test: ***p < 0.001; day 2, n = 4; day 15, n = 4 per
group). SC, satellite cell.
See also Figures S4 and S5.
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Figure 5. Deficiency of Rpt3 in Satellite Cells Results in Proliferative Defects during Muscle Regeneration In Vivo
(A) Time course for tamoxifen (Tmx) treatment and tissue harvesting. Con indicates Rpt3f/f mice and scKO indicates satellite cell-specific
Rpt3 knockout mice (Pax7CreERT2/+; Rpt3f/f).
(B) Immunostaining for Cleaved-Caspase3 (green), Pax7 (red), and DAPI (blue) in tibialis anterior (TA) muscle cryosections 3 days after
Tmx treatment. Arrows indicate satellite cells. Scale bar, 10 mm. The y axis shows the ratio of Cleaved-Caspase3-positive cells to PAX7-
positive cells. Data represent means ± SD (t test: **p < 0.01; n = 3 per group).
(C) Time course for Tmx treatment and tissue harvesting.
(D) Immunostaining for EdU (green), M-cadherin (red), and DAPI (blue) in TA muscle cryosections, 3 days after Tmx treatment. Arrows
indicate satellite cells. Scale bar, 10 mm. The y axis shows the ratio of EdU-positive cells to M-cadherin-positive cells. Data represent
means ± SD (t test: NS, no significance; n = 3 per group).
(legend continued on next page)
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The ubiquitin-proteasome system functions to degrade
most long- and short-lived normal and abnormal intracel-
lular proteins (Collins and Goldberg, 2017; Goldberg,
2003). Especially inmuscle, proteolysis by theubiquitin-pro-
teasome system is a major mechanism involved in myofi-
brillar protein degradation (Attaix et al., 1998; Hasselgren
etal., 2002).Therefore,whenexaminingproteasomeactivity
during regeneration, we found that both chymotrypsin-like
and trypsin-like proteasome activities were increased 3 days
afterCTX injection, indicating that the earlyphaseofmuscle
regeneration is associated with the activation of machinery
involved in protein degradation. Furthermore, the accumu-
lation of ubiquitinated proteins was also most accelerated
onday 3 post injury, indicating that proteasome-related pro-
teolysis wasmost enhanced at this time point. Interestingly,
MYOD,which constitutes an importantmyogenic transcrip-
tion factor for muscle regeneration (Charge and Rudnicki,
2004; Sabourin et al., 1999), was also particularly elevated
onday 3post injury. In a previous study, proteasome activity
was foundtobestronglycorrelatedwithproliferatingcellnu-
clear antigen protein levels, suggesting that the proteasome
plays a key role in myoblast proliferation (Duguez et al.,
2003). Thus, it is suggested that enhancing the proteasome
system during the early phase is an important event for
normal muscle regeneration.
Previous studies have confirmed the absolute require-
ment for Pax7-positive satellite cells duringmuscle regener-
ation (Lepper et al., 2011; Relaix and Zammit, 2012;
Sambasivan et al., 2011; von Maltzahn et al., 2013). Our
data support these findings that satellite cells are essential
formuscle regeneration.When the number of satellite cells
decreases, muscle regeneration fails. These datamight indi-
cate that the number of satellite cells is also important.
However, other cells. such as mesoangioblasts and PW1+
interstitial cells, which contribute to regeneration, have
been identified in muscle tissue (Mitchell et al., 2010; Sam-
paolesi et al., 2003). Thus, we cannot exclude the possibil-
ity that the regenerative defect in Rpt3-scKOmice at day 14
after CTX injection could be improved after a long period
of recovery by contributing to the myogenic potential of
other cells involved in regeneration (Mitchell et al., 2010;
Sampaolesi et al., 2003).
Proteasome insufficiency due to Rpt3 deficiency
increased the protein levels of Cleaved-Caspase 3 and
caused apoptosis. Furthermore, we performed immuno-
blotting analysis of Bax, Bak, Bcl-2, and Mcl-1 proteins
related to apoptosis, but there was no significant change
particularly (data not shown). A previous study reported
that the proteasome inhibitor MG132 induces caspase-3-
dependent apoptosis, and a caspase-3 inhibitor was found
to reduce MG132-induced apoptosis in human mast cells
(Westerberg et al., 2012). Our data show that proteasome
dysfunction by loss of Rpt3 is accompanied by apoptosis,
which is at least due to enhancement of the caspase 3 activ-
ity. Therefore, in this study, it is considered that apoptosis
in scKO primarymyoblasts might be alleviated by the inhi-
bition of Caspase 3.
There have been many previous studies on the associ-
ation between the proteasome system and p53. Among
these, one report suggested that the ubiquitination level
of p53 is elevated after treatment with the proteasome
inhibitor MG132 (Maki et al., 1996), suggesting that
this protein is degraded by the proteasome and that its
stability is controlled by ubiquitin-dependent degrada-
tion. Consistent with these findings, we demonstrated
p53 stability in primary myoblasts exhibiting protea-
some dysfunction (via Rpt3 ablation). p53 inhibits cell
proliferation by both blocking cell-cycle progression
and promoting apoptotic cell death (Vousden and Prives,
2009). In addition, proteasome inhibition has been
shown to induce apoptosis in several different cell types
(Concannon et al., 2007; Ding et al., 2007; Pandit and
Gartel, 2011). Therefore, we hypothesized that protea-
some dysfunction, mediated by Rpt3 deletion, results in
cell death and the inhibition of cell proliferation due
to p53 hyperactivation. Because p53 is upregulated in
Rpt3-deficient myoblasts, we examined whether knock-
down of p53 rescues the proliferation defects observed
in Rpt3-deficient myoblasts. Importantly, we found
that inhibition of p53 successfully rescued these effects,
indicating that the proteasome system in muscle
stem cells regulates cell proliferation at least in part
through p53.
Myogenesis is a complex process controlled by the
spatiotemporal expression of many MRFs and transcrip-
tion factors (Braun and Gautel, 2011; Parker et al., 2003;
Wagers and Conboy, 2005). As myoblast differentia-
tion proceeds, the timely synthesis and degradation of
(E) Immunostaining for M-cadherin (green), KI67 (red), and DAPI (blue) in TA muscle cryosections, 3 days after Tmx treatment. Arrows
indicate satellite cells. Scale bar, 10 mm. The y axis shows the ratio of KI67-positive cells to M-cadherin-positive cells. Data represent
means ± SD (t test: NS, no significance; n = 3 per group).
(F) Time course for Tmx treatment and tissue harvesting.
(G) Immunostaining for EdU (green), M-cadherin (red), and DAPI (blue) in TA muscle cryosections, 3 days after injury. Scale bar, 50 mm.
The y axis shows the number of EdU-positive and M-cadherin-positive cells per field. Data represent means ± SD (t test: **p < 0.01; n = 3
per group).
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Figure 6. Deletion of Rpt3 in Satellite Cells Induces a Proliferation Defect and Apoptosis
(A) Time course for tamoxifen (Tmx) treatment and tissue harvesting. Con indicates Rpt3f/f mice and scKO indicates satellite cell-specific
Rpt3 knockout mice (Pax7CreERT2/+; Rpt3f/f).
(B) Relative expression of Rpt3 mRNA in Pax7CreERT2/+; Rpt3f/f satellite cells treated with vehicle or 4OH-Tmx. Data represent means ± SEM
(t test: ***p < 0.001; n = 3 per group). AU, arbitrary units.
(C) Immunostaining for EdU (green) and DAPI (blue) in satellite cells treated with vehicle or 4OH-Tmx. Scale bar, 50 mm. The y axis shows
the relative ratio of EdU-positive cells. Data represent means ± SEM (t test: ***p < 0.001; n = 4 per group).
(D) Immunostaining for TUNEL (green) and DAPI (blue) in satellite cells treated with vehicle or 4OH-Tmx. Arrows indicate TUNEL-positive
cells. Scale bar, 100 mm. The y axis shows the ratio of TUNEL-positive cells to DAPI-positive cells. Data represent means ± SEM (t test:
***p < 0.001; n = 3 per group).
(legend continued on next page)
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appropriate myogenic proteins are required, which sug-
gests a significant role for adaptive proteolysis in the
myogenic process. Indeed, previous studies have reported
that the complex process of myogenic differentiation,
which begins with cell-cycle arrest and ends with the
fusion of individual myoblasts to formmultinucleatedmy-
otubes, is related to the proteasome system (Abu Hatoum
et al., 1998; Gardrat et al., 1997; Kim et al., 1998). In addi-
tion, inhibition or knockdown of the proteasome can block
the fusion ofmyoblasts and inhibit differentiation (Gardrat
et al., 1997; Kim et al., 1998). Consistent with previous
studies, proteasome dysfunction conferred by Rpt3 defi-
ciency was found to suppress the myogenic differentiation
of primary myoblasts, suggesting that proper proteasome
function is necessary for myogenic differentiation. In addi-
tion, it has been previously shown that p53 can promote
muscle differentiation in vitro (Halevy et al., 1995; Porrello
et al., 2000; Soddu et al., 1996; Tamir and Bengal, 1998;
Weintraub et al., 1991). However, despite the presence of
p53 observed in Rpt3-deficient primary myoblasts, Rpt3
ablation was shown to suppress myogenic differentiation.
This might be because p53 expression was excessive.
Indeed, a 20-fold increase in p53-positive cells was
observed in Rpt3-deficient myoblasts, as compared with
that in controls, based on immunostaining. A recent study
reported that tight control of p53 levels in myoblasts
regulates the balance between differentiation and
return to quiescence (Flamini et al., 2018), which could
indicate appropriate expression of p53 during myogenic
differentiation.
Satellite cells provide myonuclei for postnatal muscle
growth and for maintenance and regeneration in adults
(Relaix and Zammit, 2012; Yin et al., 2013), indicating
that the maintenance of satellite cells is essential for the
functional homeostasis of skeletal muscle. Moreover,
recent studies indicated that skeletal muscle disease is exac-
erbated by defective satellite cells (Crist, 2017). Impor-
tantly, we found that proteasome dysfunction by loss of
Rpt3 in satellite cells leads to a dramatic depletion of the
quiescent satellite cell pool approximately 2 weeks after
knockout induction. Previous studies demonstrated that
proteolysis by the proteasome is essential to maintain
amino acid pools (Suraweera et al., 2012; Vabulas andHartl,
2005). Although quiescent satellite cells are thought to be
associated with very low turnover in steady state condi-
tions (Lepper and Fan, 2010), minimal amino acid pools
obtained from proteolysis by the proteasome system are
necessary for the normal maintenance of cells. Therefore,
proteasome dysfunction, conferred by Rpt3 deficiency,
might have resulted in serious consequences, depriving
the cells of pooled resources for cellular maintenance. We
hypothesize that satellite cell-specific Rpt3 deficiency
might have blocked the cellular ‘‘recycling system’’ that is
essential for themaintenance of satellite cells; this question
needs to be further examined.
Rpt3 deficiency in primary myoblasts and Rpt3 knock-
down in a myoblast cell line resulted in a decrease in pro-
teasome activity, leading to apoptotic cell death. There are
several reports showing the relationship between protea-
somal activity and aging, including lifespan. During ag-
ing, proteasomal activity is decreased in several tissues,
such as the brain (Zeng et al., 2005), liver (Dasuri et al.,
2009; Hayashi and Goto, 1998), heart (Bulteau et al.,
2002), and muscle (Ferrington et al., 2005). Overexpres-
sion of proteasome subunits in yeast and Caenorhabditis
elegans has been shown to lead to an increase in protea-
some activity as well as prolonged lifespan (Chen et al.,
2006; Vilchez et al., 2012), whereas flies and mice with
a genetic decrease in proteasome activity have a shortened
lifespan (Tomaru et al., 2012; Tonoki et al., 2009). Previ-
ously, we have also reported a shortened lifespan even
in muscle-specific Rpt3-knockout mice (Kitajima et al.,
2014). Taken together, these data suggest that there is a
close relationship between the proteasome system and ag-
ing in vivo and in vitro. Whether adult somatic stem cells
also have enhanced proteasome activity remains to be
elucidated, but the maintenance of this activity might
critically affect organismal aging (Vilchez et al., 2014).
Therefore, our findings using muscle stem cells will lead
to a detailed understanding of proteolysis and its associ-
ated molecular mechanisms in muscle stem cells. Our
results show that the ubiquitin-proteasome system is
(E) Immunoblotting analysis of Cleaved-Caspase3 and GAPDH in satellite cells treated with vehicle or 4OH-Tmx.
(F) Relative ratio of DAPI-positive cells from Con or scKO mice. Data represent means ± SEM (t test: ***p < 0.001; n = 3 per group).
(G) Time course of Tmx treatment and tissue harvesting. Con siRNA indicates control siRNA transfection and Rpt3 siRNA indicates Rpt3
siRNA transfection.
(H) Immunostaining for EdU (green) and DAPI (blue) in C2C12 cells after siRNA transfection. Scale bar, 50 mm. The y axis shows the
relative ratio of EdU-positive cells. Data represent means ± SEM (t test: **p < 0.01; n = 3 per group).
(I) Immunostaining for TUNEL (green) and DAPI (blue) in C2C12 cells after siRNA transfection. Arrows indicate TUNEL-positive cells. Scale
bar, 100 mm. The y axis shows the ratio of TUNEL-positive cells to DAPI-positive cells. Data represent means ± SEM (t test: ***p < 0.001;
n = 3 per group).
(J) Relative ratio of DAPI-positive cells. Data represent means ± SEM (t test: ***p < 0.001; n = 3 per group).
See also Figures S6 and S7.
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Figure 7. p53 Knockdown in Rpt3-Deficient Satellite Cells Rescues the Defect in Proliferation
(A) DAVID v6.7 functional annotation bioinformatics microarray analysis software was used to obtain KEGG pathway functional
classification. Only KEGG pathway terms for classification that showed statistically significant differences, in terms of the number of
differentially regulated genes (satellite cells from satellite cell-specific Rpt3 mice versus satellite cells from control mice), are shown
(legend continued on next page)
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indispensable for the maintenance of muscle stem cells.
Further study is needed to understand the role of stem
cells in various physiological processes involving the pro-
teasome system; however, this work provides the funda-
mentals for understanding the regulation of proteolysis
in muscle stem cells.
EXPERIMENTAL PROCEDURES
Cell Culture
Satellite cells were cultured in GM (DMEM supplemented with
30% fetal bovine serum, 1% chick embryo extract, 10 ng/mL basic
fibroblast growth factor , and 1% penicillin-streptomycin) on cul-
ture dishes coatedwithMatrigel (BD Biosciences).Myogenic differ-
entiation was induced in DM (DMEM supplemented with 5%
horse serum and 1% penicillin-streptomycin). For in vitro genetic
deletion, 4-OH Tmx (1 mM) was added to culture medium for
2 days to induce Cre-mediated deletion.
Mouse C2C12 myoblasts were cultured in GM (DMEM supple-
mented with 10% fetal bovine serum and 1% penicillin-strepto-
mycin). The cells were transfected with 30 nM siRNA using
Lipofectamine RNAiMAX (Invitrogen).
Single Fiber Isolation
Individual myofibers were isolated from the EDL muscle as we
described previously (Kitajima et al., 2016; Ono et al., 2015). In
brief, EDL myofibers were digested using 0.2% type I collagenase
(Worthington) inDMEM for 90min at 37Cwith 5%CO2.Muscles
were mechanically dissociated and then washed five times to elim-
inate debris and contaminating cells. For immunohistochemical
analysis, EDL myofibers were immediately fixed using 4% parafor-
maldehyde (PFA, Wako) in PBS.
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